AGF Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$667M Buy
556,470
+284,422
+105% +$291M 2.59% 4
2026
Q1
$250M Buy
272,048
+186,213
+217% +$189M 1.12% 20
2025
Q4
$92.2M Sell
85,835
-30,199
-26% -$28.9M 0.4% 74
2025
Q3
$88.5M Sell
116,034
-199,667
-63% -$149M 0.39% 76
2025
Q2
$246M Sell
315,701
-188,811
-37% -$147M 1.12% 23
2025
Q1
$417M Sell
504,512
-92,653
-16% -$77.1M 2.2% 6
2024
Q4
$461M Buy
597,165
+21,212
+4% +$17.6M 2.29% 4
2024
Q3
$510M Buy
575,953
+47,791
+9% +$43M 2.58% 3
2024
Q2
$478M Sell
528,162
-1,052
-0.2% -$842K 2.65% 3
2024
Q1
$412M Buy
529,214
+94,821
+22% +$67.5M 2.28% 3
2023
Q4
$253M Sell
434,393
-5,856
-1% -$3.42M 1.49% 10
2023
Q3
$236M Buy
440,249
+46,300
+12% +$23.9M 1.68% 7
2023
Q2
$185M Buy
393,949
+331,001
+526% +$139M 1.34% 15
2023
Q1
$21.6M Buy
62,948
+59,844
+1,928% +$20.2M 0.15% 142
2022
Q4
$1.14M Buy
+3,104
New +$1.1M 0.01% 574

Other funds holding LLY

AGF Management's LLY Position: Q2 2026 in Review

AGF Management increased its Eli Lilly (LLY) stake by 105% in Q2 2026, buying an estimated $291M and bringing the position to 556,470 shares worth $667M. The position accounts for 2.59% of the portfolio, ranked #4.

AGF Management first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • AGF Management held 556,470 shares of Eli Lilly worth $667M as of Q2 2026.
  • AGF Management bought 284,422 Eli Lilly shares in Q2 2026, an estimated $291M.
  • Eli Lilly made up 2.59% of AGF Management's portfolio in Q2 2026, its #4 holding.
  • AGF Management first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.